Summary
This study investigated the protective effect of the angiotensin converting enzyme inhibitor, ramipril, on endothelium-dependent responses in arteries from control (CON) and streptozotocin-induced (STZ) diabetic rats. Three hypotheses were tested: 1) there is an endothelium-dependent component to the increased alpha-adrenergic responsiveness characteristic of diabetes; 2) endothelium-dependent, acetylcholine-induced relaxation is attenuated in aorta from diabetic rats; and 3) ramipril (3 mg/kg daily in the food, 12–15 weeks) will prevent functional vascular changes in diabetic rats. Vascular function was assessed in aortic rings using standard muscle bath procedures for measurement of isometric force. Sensitivity to phenylephrine was increased in aortic rings from diabetic compared to control values [pD2 values (-log ED50): CON=6.22±0.12, STZ=7.54±0.11), and removal of the endothelium (-Endo) increased phenylephrine sensitivity (CON-Endo=7.40±0.11, STZ-Endo=8.32±0.18). The magnitude of the shift in responsiveness following endothelium removal was greatest in control rats. Ramipril treatment (Ram) partially normalized phenylephrine responsiveness in intact (STZ + Ram=6.55±0.11) and denuded (STZ-Endo + Ram=7.75±0.10) vessels. Vasodilatation to acetylcholine and nitroglycerin was not altered in diabetic rats nor was it affected by ramipril treatment. Diabetes increases contractile sensitivity to phenylephrine but not to vasodilators and chronic ramipril treatment prevents this increase in contractile sensitivity. Ramipril treatment did not alter the hyperglycaemic condition induced by streptozotocin. The changes in phenylephrine sensitivity appear to involve an endothelial and a smooth muscle component.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- STZ:
-
streptozotocin
- ACE:
-
angiotensin converting enzyme
- EC50 :
-
agonist concentration resulting in a half maximal contraction
- NO:
-
nitric oxide
References
Doria A, Fioretto P, Avogaro A et al. (1991) Insulin resistance is associated with high lithium-sodium counter-transport in essential hypertension. Am J Physiol 261: E684-E691
Ganda O (1980) Pathogenesis of macrovascular disease in the human diabetic. Diabetes 29: 931–942
Ross H, Bernstein G, Rifkin H (1983) Relationship of metabolic control of diabetes mellitus to long-term complications in diabetes mellitus, theory and practice, 3rd edn. Medical Examination Publication, New York, p 907
Christlieb A (1973) Diabetes and hypertensive vascular disease. Mechanisms and treatment. Am J Cardiol 32: 592–606
Pfaffman M, Dudley P, Prater A (1983) Relationship between untreated and insulin-treated diabetes and vascular relaxation. Arch Int Pharmacodyn Ther 266: 131–143
Altan V, Karasu C, Ozuari A (1989) The effects of type-1 and type-2 diabetes on endothelium-dependent relaxation in rat aorta. Pharmacol Biochem Behavior 33: 519–522
Garcia M, McNamara P, Gordon I, Kannell W (1974) Morbidity and mortality in diabetics in the Framingham population: sixteen year follow up study. Diabetes 23: 104–111
Pfaffman M (1980) The effects of streptozotocin-induced diabetes and insulin-treatment on the cardiovascular system of the rat. Res Commun Chem Pathol Pharmacol 28: 27–41
Agrawal D, McNeill J (1987) Vascular responses to agonists in rat mesenteric artery from diabetic rats. Can J Physiol Pharmacol 65: 1484–1490
Durante W, Sen A, Sunahara F (1988) Impairment of endothelium-dependent relaxation in aortae from spontaneously diabetic rats. Br J Pharmacol 94: 463–468
Kamata K, Miyata N, Kasuya Y (1989) Impairment of endothelium-dependent relaxation and changes in levels of cyclic GMP in aorta from streptozotocin-induced diabetic rats. Br J Pharmacol 97: 614–618
Kamata K, Miyata N, Kasuya Y (1989) Involvement of endothelial cells in relaxation and contraction responses of the aorta to isoproterenol in naive and streptozotocin-induced diabetic rats. J Pharmacol Exp Ther 249: 890–894
Pfaffman M, Hilman R, Darby A (1980) Contractile relaxing activity of arterial smooth muscle from streptozotocindiabetic rats. Res Commun Chem Pathol Pharmacol 30: 283–299
Colwell J, Halushka P, Sarji K, Lopes-Virella M, Sagel J (1979) Vascular disease in diabetes: pathophysiological mechanisms and therapy. Arch Int Med 139: 225–230
Chang K, Stevens W (1992) Endothelium-dependent increase in vascular sensitivity to phenylephrine in long-term streptozotocin diabetic rat aorta. Br J Pharmacol 107: 983–990
Pfaffman MA, Ball CR, Darby A, Hilman R (1982) Insulin reversal of diabetes-induced inhibition of vascular contractility in the rat. Am J Physiol 242: H490-H495
Mulhern M, Docherty J (1986) Effects of experimental diabetes on the responsiveness of rat aorta. Br J Pharmacol 97: 1007–1012
Kyoung C, Stevens W (1992) Endothelium-dependent increase in vascular sensitivity to phenylephrine in long-term streptozotocin diabetic rat aorta. Br J Pharmacol 107: 983–990
Fortes Z, Leme J, Scivoletto R (1983) Vascular reactivity in diabetes mellitus: role of the endothelial cell. Br J Pharmacol 79: 771–781
Kappagoda T, Jayakody L, Rajotte R, Thomson A, Senaratne P (1989) Endothelium-dependent relaxation to acetylcholine in the aorta of streptozotocin induced diabetic-rat and the BB-diabetic rat. Clin Invest Med 12: 187–193
Wakabayashi I, Katake K, Kimura N, Kakishita E, Nagai K (1986) Modulation of vascular tonus by the endothelium in experimental diabetes. Life Sci 40: 643–648
Mayhan WG (1989) Impairment of endothelium-dependent dilation of cerebral arterioles during diabetes mellitus. Am J Physiol 256: H621-H625
Oyama Y, Kawasaki K, Hattori Y, Kanno M (1986) Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur J Pharmacol 131: 75–78
Pieper G, Gross G (1988) Oxygen free radicals abolish endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol 255: H825-H833
Pieper G, Mei D, Langenstroer P, O'Rourke S (1992) Bioassay of endothelium-derived relaxing factor in diabetic rat aorta. Am J Physiol 263: H676-H680
Matsuzaki T, Sakanashi M (1992) Comparison of the development of tolerance to nitroglycerin in aortic preparations isolated from non-diabetic and diabetic rats. Heart Vessels 7: 1–7
Clozel M, Kuhn H, Hefti F (1990) Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension 16: 532–540
Finta K, Fisher M, Lee L, Gordon D, Pitt B, Webb RC (1993) Ramipril prevents impaired endothelium-dependent relaxation in arteries from rabbits fed an atherogenic diet. Atherosclerosis 100: 149–156
Flower R (1974) Drugs which inhibit prostaglandin synthesis. Pharmacol Rev 267: 33–67
Flemming W, Westfall D, De La Lande I, Jellett L (1972) Log-normal distribution of equieffective doses of norepinephrine and acetylcholine in several tissues. J Pharmacol Exp Ther 181: 339–345
Vanhoutte P, Auch-Schwelk W, Biondi M, Lorenz R, Schini V, Vidal J (1989) Why are converting enzyme inhibitors vasodilators? Br J Pharmacol 28: 95S-104S
Momose N, Fukou K, Morimoto S, Ogihara T (1993) Captopril inhibits endothelin-1 secretion from endothelial cells through bradykinin. Hypertension 21: 921–924
Wiemer G, Scholkens BA, Becker RH, Busse R (1991) Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension 18: 558–563
Mombouli J, Vanhoutte P (1991) Kinins and endotheliumdependent relaxations to converting enzyme inhibitors in perfused canine arteries. J Cardiovas Pharmacol 18: 926–927
Egleme C, Godfraind T, Miller RC (1984) Enhanced responsiveness of rat isolated aortae to clonidine after removal of endothelial cells. Br J Pharmacol 81: 16–18
Martin W, Furchgott R, Villani G (1986) Depression of contractile responses in rat aorta by spontaneously released endothelium derived relaxing factor. J Pharmacol Exp Ther 237: 529–538
Vane J, Anggard E, Botting R (1990) Regulatory functions of the vascular endothelium. N Eng J Med 323: 27–36
Beasley D (1990) Interleukin-1 and endotoxin activate soluble guanylate cyclase in vascular smooth muscle. Am J Physiol 259: R38-R44
Busse R, Mulsch A (1990) Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Letters 275: 87–90
Charpie J, Webb R (1993) Vascular myocyte-derived nitric oxide is an autocrine that limits vasoconstriction. Biochem Biophys Res Commun 194: 763–768
Sada T, Koike H, Ikeda M, Sato K, Ozaki H, Karaki H (1990) Cytosolic free calcium of aorta in hypertensive rats. Hypertension 16: 245–261
Ito K, Koike N, Miyamoto M, Urkawa N (1980) Long term blockade of angiotensin converting enzyme alters passive ion transport of vascular smooth muscle. Life Sciences 26: 1023–1027
Rosendorff C, Patton J, Radford H, Kalliatakis B (1992) α-Adrenergic and angiotensin II pressor sensitivity in hypertensive patients treated with an angiotensin converting enzyme inhibitor. J Cardiovas Pharmacol 19(Suppl 6): S105-S109
Tierney G, Marywood J, Stokes G (1989) An in vitro study of interactions between doxazosin and enalaprilat at vascular α1-adrenoceptors. Clin Exp Pharmacol Physiol 16: 329–332
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Murray, P., Pitt, B. & Webb, R.C. Ramipril prevents hypersensitivity to phenylephrine in aorta from streptozotocin-induced diabetic rats. Diabetologia 37, 664–670 (1994). https://doi.org/10.1007/BF00417689
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00417689